Chemistry Wealth Management’s Capital One COF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$822K Buy
4,097
+1,676
+69% +$321K 0.13% 102
2026
Q1
$442K Buy
2,421
+5
+0.2% +$1.05K 0.08% 133
2025
Q4
$586K Buy
2,416
+3
+0.1% +$668 0.11% 109
2025
Q3
$513K Buy
2,413
+584
+32% +$128K 0.1% 116
2025
Q2
$389K Buy
1,829
+278
+18% +$51.9K 0.08% 125
2025
Q1
$278K Sell
1,551
-444
-22% -$83.9K 0.06% 145
2024
Q4
$356K Buy
1,995
+2
+0.1% +$346 0.08% 121
2024
Q3
$298K Buy
1,993
+3
+0.2% +$427 0.07% 136
2024
Q2
$276K Buy
+1,990
New +$279K 0.07% 137

Other funds holding COF

Chemistry Wealth Management's COF Position: Q2 2026 in Review

Chemistry Wealth Management increased its Capital One (COF) stake by 69% in Q2 2026, buying an estimated $321K and bringing the position to 4,097 shares worth $822K. The position accounts for 0.13% of the portfolio, ranked #102.

Chemistry Wealth Management first reported a position in COF in Q2 2024 and has held it in 9 quarters since. 413 funds tracked by Wall St. Rank hold COF as of Q2 2026.

  • Chemistry Wealth Management held 4,097 shares of Capital One worth $822K as of Q2 2026.
  • Chemistry Wealth Management bought 1,676 Capital One shares in Q2 2026, an estimated $321K.
  • Capital One made up 0.13% of Chemistry Wealth Management's portfolio in Q2 2026, its #102 holding.
  • Chemistry Wealth Management first reported a position in Capital One in Q2 2024 and has held it in 9 quarters since.
  • 413 funds tracked by Wall St. Rank held Capital One as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.